| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_652db2caf620405fa5ba44c1df2c11ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate |
2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_986368aa4bbf906f4123f08d9d879f55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_411c49bae0da27522d3887466af304df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a47671a823b832139e494ae0c62df72b |
| publicationDate |
2004-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2841564-A1 |
| titleOfInvention |
INSULATED NUCLEIC ACID OF 5'NTR OF HUMAN FGF-1 GENE HAVING IRES ACTIVITY |
| abstract |
The present invention relates to an isolated nucleic acid having an internal ribosome entry site (IRES) activity, said nucleotide sequence from the 5 'untranslated end (5'NTR) of the human FGF-1 gene and corresponding to one of the sequences SEQ ID 1 to SEQ ID 10. The invention also relates to an expression cassette of at least one molecule of interest in a eukaryotic cell comprising at least one of the abovementioned sequences. The cassette can be introduced directly or in vector form into a host cell so that the recombinant vectors and the host cells transfected by said vector or cassette also form part of the invention. |
| priorityDate |
2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |